Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

UPDATE: Twist Bioscience Reported Q3 Adj. EPS $(0.47) Beats $(0.55) Estimate,

Author: Benzinga Newsdesk | August 04, 2025 05:00pm

Twist Bioscience (NASDAQ:TWST) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.55) by 14.55 percent. This is a 32.86 percent increase over losses of $(0.70) per share from the same period last year.

Posted In: TWST

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist